JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 May 2008

J Neurol Neurosurg Psychiatry. Published Online First: 31 August 2007. doi:10.1136/jnnp.2007.121582
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
jnnp.2007.121582v1
79/5/574    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, S.-Y.
Right arrow Articles by Jung, H.-W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, S.-Y.
Right arrow Articles by Jung, H.-W.

Original articles

Atypical and anaplastic meningiomas: prognostic implication of clinicopathological features

Seung-Yeob Yang 1, Chul-Kee Park 2, Sung-Hye Park 3, Dong Gyu Kim 2, Young Seob Chung 2* and Hee-Won Jung 2

1 DongGuk University International Hospital, Korea, Republic of
2 Department of Neurosurgery, Seoul National University College of Medicine, Korea, Republic of
3 Department of Pathology, Seoul National University College of Medicine, Korea, Republic of

* To whom correspondence should be addressed. E-mail: yschung{at}snu.ac.kr.

Accepted 18 August 2007


*  Abstract

Objectives: To evaluate patient outcome and investigate the prognostic factors of high-grade meningiomas by adopting the 2000 World Health Organization (WHO) classification system.

Methods: Between 1986 and 2004, 74 patients were diagnosed with high-grade meningioma: 33 with atypical and 41 with anaplastic meningioma. The mean follow-up was 58.5 months. We reclassified all surgical specimens, according to the 2000 WHO classification system, using two expert neuropathologists.

Results: Forty of 74 meningiomas were reclassified as atypical meningioma and 24 as anaplastic meningioma. Overall and recurrence-free survivals were significantly longer in patients with atypical than in those with anaplastic meningioma: 142.5 versus 39.8 months and 138.5 versus 32.2 months, respectively (P < 0.001). In patients with atypical meningiomas, brain invasion and adjuvant radiotherapy were not associated with survival; however, in the brain invasion subgroup, adjuvant radiotherapy improved patients¡ survival. In patients with anaplastic meningioma, the prognostic factors were brain invasion, adjuvant radiotherapy, malignant progression, p53 overexpression, and extent of resection. The p53 overexpression was the only factor associated with malignant progression (P = 0.009).

Conclusions: The 2000 WHO classification surely has identified the truly aggressive meningiomas better than did the previous criteria. Precise meningioma grading system may help to avoid overtreatment of patients with an atypical meningioma and, once the tumor has "declared itself" by recurrence and upgrading histological features, it goes on to be a tumor poorly amenable to current therapies.


Keywords: anaplastic meningioma, atypical meningioma, histopathology, malignant progression, prognosis







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd.